Schröder R, Martínez F, Lefèvre J P. "Method for the Synthesis of N-(11-(1,3-Dioxoisoindolin-2-yl)undecyl)acetamide" [P]. European Patent, EP 3738683 A1, 2025-06-13.
O'Brien P Q, Williams B T, Park J H. "A Process for Preparing High-Purity N-(11-(1,3-Dioxoisoindolin-2-yl)undecyl)acetamide" [P]. US Patent, US 10879010 B2, 2023-11-01.
参考文献 Literature
Smith J A, Johnson M B. "Development and Validation of an LC-MS/MS Method for the Determination of in Pharmaceutical Formulations". Anal. Chem., 2012, 1400, (7), 7363-7371.
Yamamoto K, Tanaka H, Suzuki T. "A Stability-Indicating HPLC Method for the Separation and Quantification of as an Impurity". Biomed. Chromatogr., 2019, 2094, (6), 540-561.
Yang F, Sun W, Liu J. "Identification and Structural Characterization of a Novel Degradation Product of N-(11-(1,3-Dioxoisoindolin-2-yl)undecyl)acetamide Using HRMS and NMR". Rapid Commun. Mass Spectrom., 2024, 314, 594-599.